Brenda Klee, ARNP Nurse Practitioner - Women's Health Medicare: Medicare Enrolled Practice Location: 265 Commercial Blvd, Lauderdale By The Sea, FL 33308 Phone: 954-772-3960 Fax: 954-772-3981 |
News Archive
Researchers at Children's Hospital Boston and Brigham and Women's Hospital have received funding from the National Heart, Lung, and Blood Institute (NHLBI) to support their search for undiscovered gene defects that cause congenital heart disease. The $4.19 million, 6-year grant is part of the Pediatric Cardiac Genomics Consortium (PCGC), which seeks to identify genetic and epigenetic causes of human congenital heart disease, and relate genetic variants present in the congenital heart disease patient population to clinical outcomes.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellairâ„¢, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Missing a gene may be less problematic than you'd think. This is one of the conclusions that emerge from the most extensive catalogue of structural variations - changes in large sections of a person's DNA sequence - to date.
GlobalHealthFacts.org - a new and freely available website with the latest country and region-specific data on HIV/AIDS, tuberculosis, malaria and other key health indicators - was launched today by the Kaiser Family Foundation, a non-profit, private operating foundation focused on health care issues.
New drugs to treat cancer that are now emerging are the end products of research begun in the 1970s and '80s, a new study by Bentley University has found, demonstrating the importance of long-term research in bringing new therapies to market.
› Verified 4 days ago